Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

9 Jan 2019 - Yahoo News
Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the appointment of William Finger as the Company’s Executive Vice President, Precision Medicine and Biopharma Solutions, effective immediately. ...
usx:cgix

---

Cancer Genetics Terminates Proposed Merger with NovellusDx

17 Dec 2018 - Yahoo News
Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced that it has terminated the previously-announced merger agreement with NovellusDx, effective immediately. As a result of the termination ...
usx:cgix

---

Today's Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer Genetics

14 Dec 2018 - Yahoo News
NEW YORK, NY / ACCESSWIRE / December 14, 2018 / Biotech stocks Adial Pharmaceuticals and Cancer Genetics were exploding in Thursday’s session. Adial moved higher on news that the company is considering expanding AD04 to treat opioid use disorder. Shares of Cancer Genetics had no news to explain its ...
usx:cgix

---

Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates

20 Nov 2018 - Nasdaq
Cancer Genetics CGIX came out with a quarterly loss of 0 23 per share versus the Zacks Consensus Estimate of a loss of 0 16 This compares to loss of 0 16 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise
usx:cgix

---

Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates

19 Nov 2018 - Yahoo News
Cancer Genetics (CGIX) delivered earnings and revenue surprises of -43.75% and -26.58%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
usx:cgix

---

Cancer Genetics: 3Q Earnings Snapshot

19 Nov 2018 - Yahoo News
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 31 cents. Losses, adjusted for restructuring costs and costs related to mergers and acquisitions, came to 23 cents per ...
usx:cgix

---

Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates

19 Nov 2018 - Yahoo News
RUTHERFORD, N.J., Nov. 19, 2018 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular.
usx:cgix

---

Cancer Genetics Appoints Glenn Miles as Chief Financial Officer

14 Nov 2018 - Yahoo News
Cancer Genetics (CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the appointment of Glenn Miles as Chief Financial Officer, effective November 26, 2018. Additionally, Mr. Igor Gitelman, Chief Accounting Officer ...
usx:cgix

---

Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know

1 Nov 2018 - Nasdaq
Wall Street expects flat earnings compared to the year ago quarter on higher revenues when Cancer Genetics CGIX reports results for the quarter ended September 2018 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that
usx:cgix

---

Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know

1 Nov 2018 - Yahoo News
Cancer Genetics (CGIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
usx:cgix

---